Summit Therapeutics Inc. has made headlines with the recent stock transaction involving Co-CEO Robert W. Duggan. On November 16, 2026, Duggan exercised an option to purchase 500,000 shares of the company’s common stock at a price of $1.06 per share. This significant move underscores his confidence in the company’s prospects and aligns with the ongoing developments in the pharmaceutical preparations sector.
Background
Summit Therapeutics Inc., identified by the Central Index Key (CIK) 0001599298, operates within the pharmaceutical preparations industry, classified under SIC code 2834. The company trades on the Nasdaq under the ticker symbol SMMT. Summit is categorized as a large accelerated filer and has been active in recent filings, including several Form 4 submissions and an 8-K report on the same day as this transaction.
What the Filing Says
The SEC filing indicates that on November 16, 2026, Duggan acquired 500,000 shares through the exercise of stock options. The filing states, "On November 16, 2026, the Spouse of Reporting Person exercised an option to purchase 500,000 shares of the Issuer's common stock at an exercise price of $1.06 per share." Following this transaction, Duggan holds 531,000 shares directly, with additional holdings through trusts and family members.
Impact
This stock transaction may affect various stakeholders, including employees, investors, and analysts observing Summit Therapeutics' market movements. Duggan's actions signal a strong commitment to the company, which could enhance investor confidence and potentially influence the stock's performance. The pharmaceutical preparations industry, in which Summit operates, may also see reactions from competitors and market analysts as they assess the implications of this transaction.
What's Next
The filing does not say what happens next.
Read Next
Saba Capital Management Disposes of Shares in PIMCO Fund
Wang Yanjun Reports Multiple Stock Sales at Sea Ltd
Kim Vyacheslav Sells Shares of Kaspi.kz in Recent Transactions
Summit Therapeutics Co-CEO Exercises Stock Options for 500K Shares
King David Arnold buys 6,000 shares of Kratos Defense
Asterbadi Dalia Nadine Reports Stock Transaction for McEwen







